12-132490742-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001367871.1(FBRSL1):c.172G>A(p.Ala58Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000249 in 1,015,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001367871.1 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- syndromic complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Broad Center for Mendelian Genomics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBRSL1 | NM_001367871.1 | c.172G>A | p.Ala58Thr | missense_variant | Exon 1 of 19 | ENST00000680143.1 | NP_001354800.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBRSL1 | ENST00000680143.1 | c.172G>A | p.Ala58Thr | missense_variant | Exon 1 of 19 | NM_001367871.1 | ENSP00000505341.1 | |||
FBRSL1 | ENST00000434748.2 | c.172G>A | p.Ala58Thr | missense_variant | Exon 1 of 17 | 1 | ENSP00000396160.2 | |||
FBRSL1 | ENST00000650108.1 | c.172G>A | p.Ala58Thr | missense_variant | Exon 1 of 20 | ENSP00000496901.1 |
Frequencies
GnomAD3 genomes AF: 0.0000754 AC: 11AN: 145794Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 802 AF XY: 0.00
GnomAD4 exome AF: 0.000278 AC: 242AN: 870010Hom.: 0 Cov.: 28 AF XY: 0.000274 AC XY: 111AN XY: 404720 show subpopulations
GnomAD4 genome AF: 0.0000754 AC: 11AN: 145904Hom.: 0 Cov.: 31 AF XY: 0.0000704 AC XY: 5AN XY: 71066 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.172G>A (p.A58T) alteration is located in exon 1 (coding exon 1) of the FBRSL1 gene. This alteration results from a G to A substitution at nucleotide position 172, causing the alanine (A) at amino acid position 58 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with FBRSL1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 58 of the FBRSL1 protein (p.Ala58Thr). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at